Management of hypertension in the facelift patient: Results of a national consensus survey

Andrew P. Trussler, Daniel A. Hatef, Rod J. Rohrich

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Introduction: In the facelift patient, uncontrolled perioperative hypertension is a difficult, acute condition that can lead to significant complications. Although the treatment of hypertension in the ambulatory medical setting has been standardized, its management in the cosmetic surgery setting has been ambiguous.Objectives: The authors evaluate the results of a survey to assess current national trends in perioperative facelift hypertension management.Methods: A 13-question survey regarding perioperative hypertension management was sent by postal mail to 1776 members of the American Society for Aesthetic Plastic Surgery (ASAPS). Respondents were queried about their geographic location, caseload volume, facelift method, and hematoma rate.Results: A 35.4% response rate was attained (629 respondents). Superficial musculoaponeurotic system (SMAS) plication performed under general anesthesia as an outpatient procedure was the most common facelift technique. Perioperative blood pressure management was consistent among all respondents. Beta-blockers were commonly utilized throughout the preoperative period. Administration of alpha agonists was reported more frequently by surgeons with higher-volume caseloads and more years in practice. Reported hematoma rates did not vary with medication. Medical treatment at an intraoperative systolic blood pressure (SBP) threshold below 100 (p <.04) and a postoperative SBP of greater than 139 (p <.05) significantly increased reported hematoma rates.Conclusions: The data generated from the survey suggest that the timing of treating hypertension deserves more attention than the actual medication administered. Proper perioperative care of the facelift patient is paramount in the reduction of hematoma rates. Preexisting hypertension correlates with a higher hematoma rate, though this study also suggests that normotensive anesthesia, as well as strict postoperative blood pressure control did contribute to a reduction in hematoma rate.

Original languageEnglish (US)
Pages (from-to)493-500
Number of pages8
JournalAesthetic Surgery Journal
Volume31
Issue number5
DOIs
StatePublished - Jul 2011

Fingerprint

Rhytidoplasty
Hematoma
Blood Pressure
Hypertension
Plastic Surgery
Perioperative Care
Preoperative Period
Geographic Locations
Postal Service
General Anesthesia
Surveys and Questionnaires
Outpatients
Anesthesia
Therapeutics

Keywords

  • facelift
  • hematoma
  • hypertension

ASJC Scopus subject areas

  • Surgery

Cite this

Management of hypertension in the facelift patient : Results of a national consensus survey. / Trussler, Andrew P.; Hatef, Daniel A.; Rohrich, Rod J.

In: Aesthetic Surgery Journal, Vol. 31, No. 5, 07.2011, p. 493-500.

Research output: Contribution to journalArticle

Trussler, Andrew P. ; Hatef, Daniel A. ; Rohrich, Rod J. / Management of hypertension in the facelift patient : Results of a national consensus survey. In: Aesthetic Surgery Journal. 2011 ; Vol. 31, No. 5. pp. 493-500.
@article{0fa63c0ffbef47449d76e0f15025c31f,
title = "Management of hypertension in the facelift patient: Results of a national consensus survey",
abstract = "Introduction: In the facelift patient, uncontrolled perioperative hypertension is a difficult, acute condition that can lead to significant complications. Although the treatment of hypertension in the ambulatory medical setting has been standardized, its management in the cosmetic surgery setting has been ambiguous.Objectives: The authors evaluate the results of a survey to assess current national trends in perioperative facelift hypertension management.Methods: A 13-question survey regarding perioperative hypertension management was sent by postal mail to 1776 members of the American Society for Aesthetic Plastic Surgery (ASAPS). Respondents were queried about their geographic location, caseload volume, facelift method, and hematoma rate.Results: A 35.4{\%} response rate was attained (629 respondents). Superficial musculoaponeurotic system (SMAS) plication performed under general anesthesia as an outpatient procedure was the most common facelift technique. Perioperative blood pressure management was consistent among all respondents. Beta-blockers were commonly utilized throughout the preoperative period. Administration of alpha agonists was reported more frequently by surgeons with higher-volume caseloads and more years in practice. Reported hematoma rates did not vary with medication. Medical treatment at an intraoperative systolic blood pressure (SBP) threshold below 100 (p <.04) and a postoperative SBP of greater than 139 (p <.05) significantly increased reported hematoma rates.Conclusions: The data generated from the survey suggest that the timing of treating hypertension deserves more attention than the actual medication administered. Proper perioperative care of the facelift patient is paramount in the reduction of hematoma rates. Preexisting hypertension correlates with a higher hematoma rate, though this study also suggests that normotensive anesthesia, as well as strict postoperative blood pressure control did contribute to a reduction in hematoma rate.",
keywords = "facelift, hematoma, hypertension",
author = "Trussler, {Andrew P.} and Hatef, {Daniel A.} and Rohrich, {Rod J.}",
year = "2011",
month = "7",
doi = "10.1177/1090820X11411292",
language = "English (US)",
volume = "31",
pages = "493--500",
journal = "Aesthetic Surgery Journal",
issn = "1090-820X",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Management of hypertension in the facelift patient

T2 - Results of a national consensus survey

AU - Trussler, Andrew P.

AU - Hatef, Daniel A.

AU - Rohrich, Rod J.

PY - 2011/7

Y1 - 2011/7

N2 - Introduction: In the facelift patient, uncontrolled perioperative hypertension is a difficult, acute condition that can lead to significant complications. Although the treatment of hypertension in the ambulatory medical setting has been standardized, its management in the cosmetic surgery setting has been ambiguous.Objectives: The authors evaluate the results of a survey to assess current national trends in perioperative facelift hypertension management.Methods: A 13-question survey regarding perioperative hypertension management was sent by postal mail to 1776 members of the American Society for Aesthetic Plastic Surgery (ASAPS). Respondents were queried about their geographic location, caseload volume, facelift method, and hematoma rate.Results: A 35.4% response rate was attained (629 respondents). Superficial musculoaponeurotic system (SMAS) plication performed under general anesthesia as an outpatient procedure was the most common facelift technique. Perioperative blood pressure management was consistent among all respondents. Beta-blockers were commonly utilized throughout the preoperative period. Administration of alpha agonists was reported more frequently by surgeons with higher-volume caseloads and more years in practice. Reported hematoma rates did not vary with medication. Medical treatment at an intraoperative systolic blood pressure (SBP) threshold below 100 (p <.04) and a postoperative SBP of greater than 139 (p <.05) significantly increased reported hematoma rates.Conclusions: The data generated from the survey suggest that the timing of treating hypertension deserves more attention than the actual medication administered. Proper perioperative care of the facelift patient is paramount in the reduction of hematoma rates. Preexisting hypertension correlates with a higher hematoma rate, though this study also suggests that normotensive anesthesia, as well as strict postoperative blood pressure control did contribute to a reduction in hematoma rate.

AB - Introduction: In the facelift patient, uncontrolled perioperative hypertension is a difficult, acute condition that can lead to significant complications. Although the treatment of hypertension in the ambulatory medical setting has been standardized, its management in the cosmetic surgery setting has been ambiguous.Objectives: The authors evaluate the results of a survey to assess current national trends in perioperative facelift hypertension management.Methods: A 13-question survey regarding perioperative hypertension management was sent by postal mail to 1776 members of the American Society for Aesthetic Plastic Surgery (ASAPS). Respondents were queried about their geographic location, caseload volume, facelift method, and hematoma rate.Results: A 35.4% response rate was attained (629 respondents). Superficial musculoaponeurotic system (SMAS) plication performed under general anesthesia as an outpatient procedure was the most common facelift technique. Perioperative blood pressure management was consistent among all respondents. Beta-blockers were commonly utilized throughout the preoperative period. Administration of alpha agonists was reported more frequently by surgeons with higher-volume caseloads and more years in practice. Reported hematoma rates did not vary with medication. Medical treatment at an intraoperative systolic blood pressure (SBP) threshold below 100 (p <.04) and a postoperative SBP of greater than 139 (p <.05) significantly increased reported hematoma rates.Conclusions: The data generated from the survey suggest that the timing of treating hypertension deserves more attention than the actual medication administered. Proper perioperative care of the facelift patient is paramount in the reduction of hematoma rates. Preexisting hypertension correlates with a higher hematoma rate, though this study also suggests that normotensive anesthesia, as well as strict postoperative blood pressure control did contribute to a reduction in hematoma rate.

KW - facelift

KW - hematoma

KW - hypertension

UR - http://www.scopus.com/inward/record.url?scp=79960177939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960177939&partnerID=8YFLogxK

U2 - 10.1177/1090820X11411292

DO - 10.1177/1090820X11411292

M3 - Article

C2 - 21719861

AN - SCOPUS:79960177939

VL - 31

SP - 493

EP - 500

JO - Aesthetic Surgery Journal

JF - Aesthetic Surgery Journal

SN - 1090-820X

IS - 5

ER -